Day: 29 June 2021

BARCELONA, Spain, June 29, 2021 /PRNewswire/ — It’s called YouCare and is the new remote health monitoring service, based on a revolutionary new wearable technology, totally textile, washable and easy to use.

This innovation, totally made in Italy, is able to detect a large number of bio-vital parameters of the individual and transmit them, in an intelligent way, thanks to 5G.

The project focuses on the use of revolutionary textile devices like the T-shirt without metal components and with sensors naturally “set“ into the fabric. The project was presented today in front of the world press during the Mobile World Congress 2021 being held in Barcelona.

During the event, ZTE iterated that they are particularly proud to be partner in this extraordinary innovation and firmly believe that 5G technology is the key to a better quality of life. ZTE further emphasized that they believe in talent and capabilities and want to keep giving their contribution to the Italian and the global technological development. For this reason, starting from next fall, ZTE will initiate the YouCare 5G test in the Innovation and Research Center located in L’Aquila.

YouCare enables the detection of bio-vital parameters, such as a “real” electrocardiogram, a respiratory act analysis, the components of the sweat, the muscle effort, and the body temperature, that has never been detected by textile sensors. The T-shirt allows the transmission, via ultra-fast 5G ZTE connection, to health centers and control, as well as to individual users.

“It is an invention that will change the life and the quality of home and remote medical assistance to many citizens experiencing health problems and vulnerable people suffering from chronic diseases, ensuring accessibility to care services and the support of our national and international network,” said Francesco Rocca, Chairman of Italian Red Crossand IFRC. “We have been working on the project since 2018 and today we are able to present the results of this important experimentation, born in the most difficult moment of the Covid emergenc. This experimentation allows us to think with pride about the path made so far and to look to the future with hope and certainty of having demonstrated the commitment, the ability and the dedication of Red Cross network, to use and to disseminate new technologies for the service of the people and of the society.”

The textile technology, patented and certified, develops new services for the protection of health in the areas of telemedicine, work, sport, and the general well-being of an individual.

By monitoring health, stress, and active living behaviors, it improves the safety of people, of the elderly, and of the sportive people.

The bio-vital parameters of YouCare, detected by imperceptible polymeric sensors “set” in the fabric, are sent to a miniaturized control unit that records the data, converts them into digital format, and ultimately sends, thanks to 5G, to a bidirectional platform transmitting them to the user’s smartphone or smartwatch in addition to a remote unit that analyzes the values with the medical software.

“From the very first moment – said Umberto Sgambati, CEO of Proger Group spa that, through the Start-Up Let’s Web-earable Solutions, has created the “Smart T-shirt” sensor – we have believed and invested in what seemed to us a totally revolutionary idea that today is a concrete reality. Certified as a Medical Device, it has been enriched by the predictive algorithms of cardiovascular disorders of BSP-Medical the world leader in the field of Medical Data Science“.

About ZTE

ZTE is a provider of advanced telecommunications systems, mobile devices and enterprise technology solutions for consumers, operators, businesses and public sector customers. As part of ZTE’s strategy, the company is committed to providing customers with end-to-end integrated innovations to deliver excellence and value as the telecommunications and information technology sectors converge. Listed on the Hong Kong and Shenzhen stock exchanges (stock code H: 0763.HK / stock code A: 000063.SZ), ZTE sells its products and services in more than 160 countries.

Media Contacts:

Alessio De Sio
ZTE Italia
Tel: +39 366 682 4010
Email: alessio.desio@zte.com.cn

• Seegene unveils “MOBILE STATION” at the Medlab Middle East 2021
• Mobile laboratory designed for mass testing at schools, airports, or communities, delivering test results within 3h 30min with the maximum testing capacity of 7,500 a day
• The biotechnology firm to sign an MOU with G42 Healthcare, a leading health-tech company based in Abu Dhabi, expanding diagnostics business opportunity in the Middle East

SEOUL, South Korea, June 29, 2021 /PRNewswire/ — South Korea’s leading biotechnology firm Seegene Inc. (KQ 096530) today introduced its new deployable container laboratory “MOBILE STATION”, at the Medlab Middle East 2021, the world’s largest medical laboratory and In Vitro Diagnostic exhibition which is taking place in Dubai from June 21 to 24.

Seegene’s MOBILE STATION, an innovative laboratory-on-wheels facility, is designed to deploy the gold standard PCR testing solution to anywhere community-based testing is needed. While many countries around the world are planning to re-open their borders, schools, and public-use facilities, MOBILE STATION is considered an ideal option for conducting mass PCR testing in such locations. Also, MOBILE STATION can be mobilized anytime, allowing more people to utilize molecular diagnostics when needed.

MOBILE STATION sets the new bar of PCR lab setting with its ability to deliver effective testing solutions to anywhere testing is needed. PCR testing has been normally conducted only at fixed space due to concerns of cross-contamination. However, MOBILE STATION, with Seegene’s technology and know-how gained through operation of South Korea’s largest reference laboratory, has already minimized the overall risks of aerosol contamination posed in PCR process by installing Class 2 (A2) Bio-Safety Cabinet and negative pressure room.

From sample collection to automated interpretation of results, it offers streamlined and automated workflow backed by the company’s All-in-One platform thereby allowing equitable access to health care for the public. Seegene’s All-in-One platform, when fully utilized, can conduct up to 7500 tests per day with a turnaround time of 3.5 hours.

Seegene’s pioneering concept of the mobile laboratory is expected to play a significant role in stopping the current pandemic since Seegene offers unparalleled PCR testing solution with its exclusive multiplex assays including Allplex™ SARS-CoV-2 Master Assay, a kit that simultaneously detects COVID-19 and multiple virus variants and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, a kit differentiates 8 target genes including Flu A, Flu B, RSV A/B and three different target genes of COVID-19. MOBILE STATION is also fully compatible with Seegene’s more than 150 multiplex assay menus including tests for respiratory infectious pathogens, HPV, STI, and GI.

Seegene also introduced ‘Combo Swab’, a self-administrable sample collection device. In comparison to nasopharyngeal swab, typically used in sampling for COVID-19 PCR testing, in which health care providers collect samples by inserting a swab deep inside nostrils, Combo Swab allows individuals to simply collect samples with two individual swabs through swirling around their nasal and oral cavity by two individual swabs without any discomfort. In addition, Combo Swab with dual sample collection showed the same accuracy compared to nasopharyngeal swab. Self-sample collection availability of Combo Swab along with provisional space scalability of MOBILE STATION enables mass testing to be proceed in a quicker time and more efficient manner than the conventional process.

Meanwhile, ‘Seegene Middle East,’ the company’s Middle East subsidiary, signed an MOU on the same day, with Group 42 healthcare, a leading Information Technology and healthcare company to promote the MOBILE STATION in the Middle East and North Africa.

Min-cheol Lee, Seegene’s Chief Technology Officer said, “As COVID-19 is likely to become endemic, the MOBILE STATION will play a key role in not only detecting COVID-19, but also closely monitoring other new viruses that can threaten our daily lives in the future. Seegene’s multiple virus variant detection kits can detect the new strains of virus and prevent them from turning into an additional outbreak of subsequent pandemic waves.

U.S. Media Contact:

Kristin Schaeffer
E: kschaeffer@cglife.com

Logo – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg

Seegene Inc. Jessica Jiyoung Park, P: +82-2-2240-6164, E: jypark2@seegene.com

KUALA LUMPUR, Malaysia, June 29, 2021 /PRNewswire/ — It was a slew of firsts as Professor Sir Alimuddin Zumla received his prize as the recipient of the 2020 Mahathir Science Award (MSA), the most prestigious international science award for Tropical Sciences. This is the first time a recipient of the Award has been presented with the prize abroad as Sir Alimuddin received the prize at the Malaysian High Commission in London, where he lives. In previous years, the prize has been presented by the Malaysian King in a private ceremony in Malaysia.

This year’s prizegiving ceremony, which was officiated by the former Malaysian Prime Minister Tun Dr. Mahathir Mohamad, was also the first time the ceremony was held virtually and broadcast live.

Sir Alimuddin has been awarded the Mahathir Science Award in Tropical Medicine in recognition of his outstanding contributions to global health, particularly in tropical infectious diseases. His research and capacity development work across multiple countries have allowed for improved health policy and outcomes for people suffering from tuberculosis, TB/HIV co-infections and infectious diseases with epidemic potential.

Sir Alimuddin, who was born and raised in Zambia, is currently a Professor of Infectious Diseases and International Health at University College London, UK and Consultant Infectious Diseases Physician at UCL Hospitals NHS Foundation Trust, London.

Utilizing his extensive experience in infectious diseases and global collaboration, he also played a role in initiating multidisciplinary collaborative research, capacity building, training and advocacy projects for COVID-19 with collaborators from China, Portugal, Italy, France, Ireland, Africa and the Middle East.

In his acceptance speech for the award, Sir Alimuddin said that individual efforts do not win prizes and medals.

“Throughout my career, I’ve been fortunate enough to work with thousands of wonderful people worldwide. The Award of the very prestigious Mahathir Science Award to me, reflects the commitment, dedication and hard work of my research teams, collaborators and friends across the world,” he said.

Nominees for the Mahathir Science Award go through a rigorous selection process modelled on the Nobel Prize (scientific) selection procedures to ensure that the Award is presented to the best candidate. MSA Laureates receive USD100,000, a solid gold medal and a certificate as their prize.

Click here to view the event video.

Photo – https://mma.prnewswire.com/media/1553564/UCL_Professor_from_Zambia_Receives_International_Science_Award.jpg